Why Aeris Resources, EOS, Novonix, and Synlait Milk shares are charging higher today

These shares are starting the week with a bang. But why?

| More on:
A woman wearing a yellow shirt smiles as she checks her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • A copper miner's shares rise 2.5% after identifying a significant mineralisation volume at the Golden Plateau deposit, enhancing life-of-mine potential.
  • Defence and space company's shares jump 12% after a sales update highlights a substantial contract backlog and potential revenue increase.
  • Battery materials company's shares climb 16.5% after achieving a milestone in mass production of synthetic graphite for industrial applications.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on track to start the week with a decent gain. At the time of writing, the benchmark index is up 0.65% to 8,843.6 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Aeris Resources Ltd (ASX: AIS)

The Aeris Resources share price is up 2.5% to 48.7 cents. This follows the release of the copper miner's update on activities at the Golden Plateau deposit. It is located within the company's 100% owned Cracow tenement package in Queensland. Management notes that a large volume of mineralisation has been identified around the historical underground workings, extending down to 150m below the bottom of the existing pit. Executive Chairman, Andre Labuschagne, said "The historical production from the Golden Plateau area highlights the significance of this mineralised system. We are highly encouraged by the potential impact this near-term ore source could have on extending the Cracow life-of-mine plan. Aeris is prioritising exploration at Golden Plateau with the drill program to be completed this financial year."

Electro Optic Systems Holdings Ltd (ASX: EOS)

The EOS share price is up 12% to $9.39. This has been driven by the release of a sales update from the defence and space company today. EOS revealed that it is expecting its full year revenue from existing contracts to be $115 million to $125 million in FY 2025. However, it is pursuing orders that could boost this number by $25 million. In addition, its contract backlog is approximately $299 million. This is $163 million higher than it was at 31 December 2024 and it still has an extensive pipeline of sales opportunities.

Novonix Ltd (ASX: NVX)

The Novonix share price is up 16.5% to 49.5 cents. Investors have been buying this battery materials and technology company's shares after it achieved a critical milestone. Novonix announced that it has delivered its first mass production, commercial-grade sample of synthetic graphite for industrial applications. It notes that this delivery has been made to one of North America's largest value-added carbon processors with a global market reach. Novonix's CEO, Mike O'Kronley, said: "We're pleased to have hit this significant manufacturing milestone. This demonstrates that industrial-grade products can be produced using NOVONIX's proprietary continuous graphitization furnace technology at a mass production scale and is another step towards bringing our battery-grade materials to market."

Synlait Milk Ltd (ASX: SM1)

The Synlait Milk share price is up 15% to 72 cents. This follows the release of the dairy processor's full year results this morning. The company revealed the more than doubling of its underlying EBITDA to NZ$107.2 million in FY 2025. In addition, Synlait Milk has signed an agreement to sell its North Island assets to global healthcare leader Abbott Laboratories (NYSE: ABT). The divestment will deliver the company approximately NZ$307 million in proceeds.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Abbott Laboratories and Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »